128 related articles for article (PubMed ID: 20739900)
1. Naproxen-induced ST-elevation myocardial infarction in a 33-year-old man.
Abuzetun JY; Satpathy R; Suker M; Elder M; Mooss A
J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):471-3. PubMed ID: 20739900
[No Abstract] [Full Text] [Related]
2. Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugs.
Grimaldi-Bensouda L; Rossignol M; Danchin N; Steg PG; Bessede G; Ovize M; Cottin Y; Autret-Leca E; Benichou J; Abenhaim L;
Heart; 2011 Nov; 97(22):1834-40. PubMed ID: 21880652
[TBL] [Abstract][Full Text] [Related]
3. Naproxen still rules.
Duke Med Health News; 2007 Jan; 13(1):2. PubMed ID: 17301989
[No Abstract] [Full Text] [Related]
4. Naproxen-induced fixed drug eruption: a case report.
Akyazi H; Baltaci D; Mungan S; Kara IH
Hum Exp Toxicol; 2011 Nov; 30(11):1872-4. PubMed ID: 21357631
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of cardiovascular events with coxibs and NSAIDs.
Emery P; Moore A; Hawkey C
Lancet; 2005 Apr 30-May 6; 365(9470):1538. PubMed ID: 15866301
[No Abstract] [Full Text] [Related]
6. [Overestimated].
Höer A; Häussler B
Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
[No Abstract] [Full Text] [Related]
7. Naproxen-induced generalized bullous fixed drug eruption.
Leivo T; Heikkilä H
Br J Dermatol; 2004 Jul; 151(1):232. PubMed ID: 15270899
[No Abstract] [Full Text] [Related]
8. The lessons of Vioxx--drug safety and sales.
Waxman HA
N Engl J Med; 2005 Jun; 352(25):2576-8. PubMed ID: 15972862
[No Abstract] [Full Text] [Related]
9. Is rofecoxib safer than naproxen?
Adelman A
J Fam Pract; 2001 Mar; 50(3):204. PubMed ID: 11252204
[No Abstract] [Full Text] [Related]
10. Naproxen induced thrombocytopenia: a case report.
Hunt PJ; Gibbons SS
N Z Med J; 1995 Nov; 108(1012):483-4. PubMed ID: 8538977
[No Abstract] [Full Text] [Related]
11. The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor.
Warner JJ; Weideman RA; Kelly KC; Brilakis ES; Banerjee S; Cunningham F; Harford WV; Kazi S; Little BB; Cryer B
J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):252-60. PubMed ID: 18787084
[TBL] [Abstract][Full Text] [Related]
12. NSAIDS and the risk of myocardial infarction: do they help or harm?
Bhatt DL
Eur Heart J; 2006 Jul; 27(14):1635-6. PubMed ID: 16782714
[No Abstract] [Full Text] [Related]
13. Fixed drug eruptions: a case report and review of the literature.
Gendernalik SB; Galeckas KJ
Cutis; 2009 Oct; 84(4):215-9. PubMed ID: 19911677
[TBL] [Abstract][Full Text] [Related]
14. [Do selective COX-2-inhibitors increase the risk of myocardial infarction?].
Otterstad JE
Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3434-5. PubMed ID: 14713991
[No Abstract] [Full Text] [Related]
15. Selective cyclooxygenase 2 inhibitors and cardiovascular events.
Solomon DH
Arthritis Rheum; 2005 Jul; 52(7):1968-78. PubMed ID: 15986365
[No Abstract] [Full Text] [Related]
16. COX 2 inhibitors may increase risk of heart attack.
Gottlieb S
BMJ; 2001 Sep; 323(7311):471. PubMed ID: 11532833
[No Abstract] [Full Text] [Related]
17. Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?
Aarntzen EH; van Riel PL; Barrera P
Ann Rheum Dis; 2005 Oct; 64(10):1523-4. PubMed ID: 16014669
[No Abstract] [Full Text] [Related]
18. Pain medications. Options may be changing.
Mayo Clin Health Lett; 2005 May; 23(5):4-5. PubMed ID: 15986506
[No Abstract] [Full Text] [Related]
19. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
[TBL] [Abstract][Full Text] [Related]
20. Rofecoxib-induced pseudoporphyria.
Markus R; Reddick ME; Rubenstein MC
J Am Acad Dermatol; 2004 Apr; 50(4):647-8. PubMed ID: 15034522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
